Barry Steele
Analyst · Michael Lew with Needham & Company
I am here, and thank, you Dan. The second quarter 2012 represents the fourth quarter where the results of W.E.T. are included for the full period. Because the acquisition had such a dramatic effect on our statement of operations and balance sheet when compared to the prior year's second quarter, I'll keep my comments limited once again to observations related to the sequential comparisons of the second quarter of 2012 with the first quarter of 2012.
Our product revenues for the second quarter of 2012 were $136.2 million, which represented an increase of $6.6 million, or 5% over the first quarter 2012 product revenue. The increase is due to higher revenues at Gentherm of $4.2 million and higher revenues of W.E.T. totaling $2.5 million.
The higher revenues for Gentherm are primarily attributable to higher production orders from our customers based in Japan and Korea, which had experienced lower volumes during the first quarter due to orders that were pulled ahead to 2011. So in essence, we're back to our normal run rates with these customers in the second quarter.
W.E.T. benefited from strong orders from its North American customers and steady revenues in Europe and Asia. However, due to the weakening of the European euro, W.E.T.’s euro-denominated revenue was lower when translated in U.S. dollars by approximately $500,000, when compared to the first quarter. So there was a bit of a deterioration just due to the euro weakening and that exposure.
Our gross margin for the second quarter was the same as that of the first quarter. Our improved fixed-cost coverage was offset primarily by higher material costs during the quarter. Operating expenses were $25.4 million during the second quarter 2012, representing an increase of $1.3 million or 7% over the first quarter. This increase is primarily due to costs associated with our program to implement the requirements of the Sarbanes-Oxley Act at W.E.T., higher legal expenses, and higher research and development expenses.
We expect our Sarbanes-Oxley Act implementation cost to the steady in the third quarter, but then go down as we go through the fourth quarter and beyond as we complete the implementation.
Our adjusted EBITDA was $17.8 million during the second quarter, which was $2 million higher than that of the first quarter of 2012. This increase was primarily due to higher revenue, lower realized derivative losses, offset partially by the increase in operating expenses. Turning now to the balance sheet and primarily focusing on our cash. Our cash, which totaled $77.3 million at the end of the quarter, decreased by $23.3 million during the second quarter.
We used some of our cash reserves for several items. These include, first, we repaid $11.8 million on our long-term debt facilities, which included a mandatory prepayment totaling approximately $8.3 million associated with W.E.T.'s sale of treasury shares. By the way, approximately $6.3 million of that expenditure was coming from Gentherm -- Gentherm acquired a significant stake of those shares. We also used $8.7 million of our pay, of our cash to pay our quarterly installment on our Series C convertible preferred stock. The remaining amounts due on the preferred stock after that payment are $41.2 million, including, which includes dividend payments. These amounts are due on a quarterly basis over the next 4 quarters.
We also invested $7.8 million in a series of derivative securities designed to counterhedge W.E.T.'s cash-related swap, or CRS, exposure. This is a derivative that we acquired in the transaction that is an exposure to the Swiss franc as we put these derivatives in place to counterhedge any potential deterioration in that relationship.
We also invested $5.0 million in capital expenditures a portion of which included the beginning of an expansion of the W.E.T. China manufacturing location. Our operating cash flow was $10.8 million for the quarter, which was reduced by approximately $4 million in working capital expansion, which was related to the higher revenue line. And that’s what I have Dan, back to you.